Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The Utility of Granulocyte Colony Stimulating Factor in Patients Receiving Chimeric Antigen Receptor T-Cell Therapy with Axicabtagene Ciloleucel

Jason N Barreto, PharmD, Corina J Doleski, PharmD, Justin R Hayne, PA-C, Matthew A Hathcock, Tuan A Truong, Stephen M. Ansell, MD PhD, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Yi Lin, MD PhD, Patrick B. Johnston

Blood (2020) 136 (Supplement 1): 23–25.

https://doi.org/10.1182/blood-2020-142150

Published: 2020

Journal Articles

Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Arushi Khurana, MBBS, Abdullah S. Al Saleh, MBBS, Sangeetha Gandhi, MBBS, Tuan A Truong, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Patrick B. Johnston, Stephen M. Ansell, MD PhD, Yi Lin, MD PhD

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-141058

Published: 2020

Journal Articles

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Paul J. Hampel, MD, Sameer A. Parikh, MD, Timothy G. Call, MD, Mithun Vinod Shah, MD PhD, Nabila Bennani, MD, Aref Al-Kali, MD, Kari G Rabe, Yucai Wang, MDPhD, Eli Muchtar, MD, Jose F. Leis, MD PhD, Saad S. Kenderian, MB, ChB, Amber B. Koehler, PA-C, MS, Susan M. Schwager, Daniel L. Van Dyke, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Min Shi, MDPhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-134586

Published: 2020

Journal Articles

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

Arushi Khurana, MBBS, Matthew A Hathcock, Thomas M. Habermann, MD, Abdullah S. Al Saleh, MBBS, Sangeetha Gandhi, MBBS, Tuan A Truong, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Stephen M. Ansell, MD PhD, David J. Inwards, MD, Luis F. Porrata, MD, Patrick B. Johnston, Ivana Micallef, MD, Yi Lin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142511

Published: 2020

Journal Articles

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Antonious Hazim, Gordon Ruan, MD, Aishwarya Ravindran, MBBS, Jithma P. Abeykoon, MD, Caleb J Scheckel, DO, Robert Vassallo, MD, Jay Ryu, MD, W. Oliver Tobin, MB BCh, Matthew Koster, MD, Nabila Bennani, MD, Karen Rech, MD, Jason R Young, MD, Mithun Vinod Shah, MD PhD, Gaurav Goyal, MD, Ronald S. Go, MD

Blood (2020) 136 (Supplement 1): 45.

https://doi.org/10.1182/blood-2020-136861

Published: 2020

Journal Articles

Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations

Susmita Sakruti, MD, Nabila Bennani, MD, Swapna Thota, MD, Rohan Garje, MD, Adewale Fawole, MD, Paul Elson, ScD, Abdo Haddad, MD, Timothy Spiro, M.D., Hamed Daw, M.D.

Blood (2013) 122 (21): 5055.

https://doi.org/10.1182/blood.V122.21.5055.5055

Published: 2013

NARROW

The Utility of Granulocyte Colony Stimulating Factor in Patients Receiving Chimeric Antigen Receptor T-Cell Therapy with Axicabtagene Ciloleucel

Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations

Email alerts

ASH Publications

American Society of Hematology

The Utility of Granulocyte Colony Stimulating Factor in Patients Receiving Chimeric Antigen Receptor T-Cell Therapy with Axicabtagene Ciloleucel

Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only